News
Important Only
Amermin Wins $11.5M Grant To Scale Breakthrough Critical Materials And Minerals Technology
Jan 5 (Reuters) - Amermin:AMERMIN WINS $11.5M GRANT TO SCALE BREAKTHROUGH CRITICAL MATERIALS AND MINERALS TECHNOLOGYAMERMIN: AWARDED GRANT FROM U.S. DEPARTMENT OF ENERGY'S OFFICE OF FOSSIL ENERGY AND CARBON MANAGEMENTReuters
Mon, Jan 5
Spartan Delta Corp Announces 2026 Guidance And Operations Update
Jan 5 (Reuters) - Spartan Delta Corp SDE.TO:SPARTAN DELTA CORP. ANNOUNCES 2026 GUIDANCE AND OPERATIONS UPDATESPARTAN DELTA CORP - PLANS $410-$470 MILLION CAPITAL PROGRAM FOR 2026SPARTAN DELTA CORP 2026 OUTLOOK AVERAGE PRODUCTION 50,000 – 52,000 BOE/DReuters
Mon, Jan 5
Mizuho lowers AutoZone to 'neutral' on lukewarm quarterly results
Mizuho downgrades auto parts retailer AutoZone AZO.N to "neutral" from "outperform"Lowers PT to $3,550 from $3,850; new PT represents 7.5% upside on stock's last close "Following another miss in fiscal Q1 and signals of elevated operating expenses, we view Street estimates as...Reuters
Mon, Jan 5
MPM BioImpact-backed Aktis Oncology seeks up to $840 million valuation in US IPO
Jan 5 (Reuters) - Aktis Oncology is seeking a valuation of as much as $840 million in its U.S. initial public offering, the biotechnology company backed by major sector investor MPM BioImpact revealed in a filing on Monday.The IPO market stirred back to life last year as record-high levels and stead...Reuters
Mon, Jan 5
Taiwan prosecutors file new indictments in Tokyo Electron trade secrets case
Follows charges against Tokyo Electron Taiwan in DecemberTaiwanese prosecutors seeking additional fineJapanese parent company has said it has not been indictedBy Wen-Yee Lee TAIPEI, Jan 5 (Reuters) - Taiwanese prosecutors said on Monday they had filed additional indictments against the Taiwanese ...Reuters
Mon, Jan 5
CORRECTED-Crinetics Pharmaceuticals reports prelim Q4 net product revenue
OverviewPharmaceutical company's preliminary Q4 net product revenue exceeded $5 mlnCompany reports positive Phase 2 CAH study results with atumelnantPreliminary results subject to completion of financial closing proceduresOutlookCompany did not provide specific financial guidance for future quar...Reuters
Mon, Jan 5
Zenas BioPharma's immune disorder drug meets main goal in late-stage trial
Jan 5 (Reuters) - Zenas BioPharma ZBIO.O said on Monday its experimental drug cut the risk of disease flare-ups in a late-stage study of patients with a rare immune system-related condition that can damage organs over time.The company said patients who received the drug candidate, obexelimab, saw a...Reuters
Mon, Jan 5
Italy to back Mercosur deal clearing major hurdle for trade agreement, Bloomberg reports
Jan 5 (Reuters) - Italy plans to support a European trade deal with the South American Mercosur bloc, Bloomberg News reported on Monday, clearing a major hurdle for the contentious free trade agreement which has been in the making for about two and a half decades.Reuters could not immediately verify...Reuters
Mon, Jan 5
UK's pharma regulator could issue a decision for Novo's Wegovy pill by year-end
LONDON, Jan 5 (Reuters) - Britain's medicines regulator said on Monday it was reviewing Novo Nordisk's NOVOb.CO application for an oral 25 milligram version of its weight-loss drug Wegovy and anticipated making a decision before the end of the year. Novo is launching its once-daily Wegovy pi...Reuters
Mon, Jan 5
Airbus delivered 793 jets in 2025, sources say
By Tim Hepher PARIS, Jan 5 (Reuters) - Airbus AIR.PA delivered 793 airplanes in 2025, industry sources said, reaching its key industrial target after the goal was reduced in the wake of production snags. Airbus last month lowered its target for the year to “around 790” jets from “around ...Reuters
Mon, Jan 5
Syria, Israel resume U.S.-mediated security talks
Jan 5 (Reuters) - U.S.-mediated talks between Syria and Israel have resumed after an interruption of several months, Syria's state news agency SANA reported on Monday, with Damascus seeking withdrawal of Israeli troops from territory seized after the fall of Bashar al-Assad.SANA, citing a Syrian...Reuters
Mon, Jan 5
DIARY-Political and General News Events from January 5
Jan 5 (Reuters) - For other diaries, please see:Political and General News POL/DIARYTop Economic Events M/DIARYEmerging Markets Economic Events EMRG/DIARYGovernment Debt Auctions D/DIARYU.S. Federal Reserve FED/DIARYToday in Washington WASH/DIARY ------------------------------------------------...Reuters
Mon, Jan 5
